✦ LIBER ✦

Integrating Epidermal Growth Factor Receptor Assay With Clinical Parameters Improves Risk Classification for Relapse and Survival in Head-and-Neck Squamous Cell Carcinoma

✍ Scribed by Christine H. Chung; Qiang Zhang; Elizabeth M. Hammond; Andy M. Trotti III; Huijun Wang; Sharon Spencer; Hua-Zhong Zhang; Jay Cooper; Richard Jordan; Marvin H. Rotman; K. Kian Ang

Book ID: 118455152
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 605 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2010.05.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterization, quantification, and po

Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas

✍ Dr. José Santini; Dr. Jean-Louis Formento; Dr. Mireille Francoual; Dr. Gérard Mi 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 661 KB

Epidermal growth factor (EGF) stimulates the growth of several types of epithelial tissues and possesses a strong mitogenic activity that is mediated through its cell surface receptor (EGFR). The aim of this study was to characterize EGFR and measure its levels in head and neck tumors biopsies (70 p

Factors associated with clinical benefit

Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck

✍ Ezra Eddy Wyssam Cohen; Anna B. Halpern; Kristen Kasza; Masha Kocherginsky; Rosa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Radiolabeled cetuximab: Dose optimizatio

Radiolabeled cetuximab: Dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model

✍ Bianca A.W. Hoeben; Janneke D.M. Molkenboer-Kuenen; Wim J.G. Oyen; Wenny J.M. Pe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 563 KB

## Abstract Noninvasive imaging of the epidermal growth factor receptor (EGFR) in head‐and‐neck squamous cell carcinoma could be of value to select patients for EGFR‐targeted therapy. We assessed dose optimization of ^111^Indium‐DTPA‐cetuximab (^111^In‐cetuximab) for EGFR imaging in a head‐and‐neck

The fibroblast growth factor receptor 4

The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma

✍ Valéria Cristina da Costa Andrade; Orlando Parise Jr.; Cora Pereira Hors; Polian 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Survey of the use of tests for human pap

Survey of the use of tests for human papilloma virus and epidermal growth factor receptor for squamous cell carcinoma of the head and neck in UK head and neck multidisciplinary teams

✍ Abdul Ahmed; Luke Cascarini; Ann Sandison; Peter Clarke 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Overexpression of epidermal growth facto

Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion

✍ Pornchai O-Charoenrat; Peter Rhys-Evans; Helmout Modjtahedi; William Court; Gary 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 277 KB 👁 3 views

Numerous reports have shown an association between overexpression of the epidermal growth factor receptor (EGFR), and poor prognosis in head and neck squamous cell carcinomas (HNSCC), however, the underlying mechanisms are still unclear. In the present study, we set out to determine whether EGFR exp